Abstract:In the title isoquinolinedione derivative, C(16)H(16)N(2)O(3)S, the piperidine ring in the tetrahydroisoquinoline ring system adopts a distorted envelope conformation. The thiazole ring is essentially planar [maximum deviation = 0.004 (1) angstrom] and is inclined at a dihedral angle of 31.08 (3)degrees with respect to the mean plane through the tetrahydroisoquinoline ring system. In the crystal structure, intermolecular O-H center dot center dot center dot O and C-H center dot center dot center dot O interactions link adjacent molecules into a three-dimensional extended network. The crystal structure is further stabilized by weak C-H center dot center dot center dot pi interactions.

Methyl 4&#8242;-isobutyl-2,2&#8242;-dimethyl-1,3-dioxo-2,3-dihydro-1H,4&#8242;H-spiro[isoquinoline-4,5&#8242;-oxazole]-4&#8242;-carboxylate

Methyl 4′-Isobutyl-2,2′-dimethyl-1,3-dioxo-2,3-dihydro-1h,4′h-spiro[isoquinoline-4,5′-oxazole]-4′-carboxylate

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

4-[(2,4-Dimethylthiazol-5-yl)methyl]-4-hydroxy-2-methylisoquinoline-1,3(2h,4h)-dione

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

(1′S,4′S)-5-(2,5-Dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(1′S,4′s)-5-(2,5-dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

Ethyl 8,13-dioxo-8,13-dihydrobenz[5,6]indolo[2,1-a]isoquinoline-14- carboxylate

(E)-4-chloro-2-{[4-(3,5-dichloro-pyridin-2-yl-oxy)phenyl-imino]-meth-yl}phenol.

Phen-yl(pyrrolo[2,1-a]isoquinolin-3-yl)methanone.

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

4-Hydroxy-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one

3-Mesityl-2-oxo-1-oxaspiro-[4.4]non-3-en-4-yl Benzoate.

Methyl 4&amp;#8242;-isobutyl-2,2&amp;#8242;-dimethyl-1,3-dioxo-2,3-dihydro-1H,4&amp;#8242;H-spiro[isoquinoline-4,5&amp;#8242;-oxazole]-4&amp;#8242;-carboxylate